Replies to post #18251 on Mymetics Corp (MYMX)

[Staypositive1]

From Stallergenes press release.

The results of this new study demonstrate the potential of COP-virosomes in allergy immunotherapy treatments. During these unprecedented times, Stallergenes Greer remains committed to furthering research to provide patients with long-lasting relief from the burden of allergies and improving their quality of life,” concluded Amer Jaber, Executive VP Operations Europe and President of Stallergenes SAS.

[TheHungryHippo]

LET IT RUN! DONT SELL SHIT!!!! WE GOT THIS!